Clinical trial
Glucose and Lipid Metabolism on Antipsychotic Medication
NCT00515723
Study timeline
Study start (unknown)2001-09-01Date precision: month
Registry last updated2019-10-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Schizoaffective Disorderunresolved
Type 2 Diabetes Mellitusunresolved
Hyperglycemiaunresolved
Interventions
risperidoneDRUG · verified · RxNorm: risperidone
olanzapineDRUG · verified · RxNorm: olanzapine
quetiapineDRUG · verified · RxNorm: quetiapine
ziprasidoneDRUG · verified · RxNorm: ziprasidone
Sponsors & collaborators
Washington University School of Medicinelead sponsor
National Institute of Mental Health (NIMH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00515723 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.